2020 Form 10-K Financial Statement

#000089710121000169 Filed on March 11, 2021

View on sec.gov

Income Statement

Concept 2020 2019 Q4 2019
Revenue $8.300M $3.450M $8.300M
YoY Change 0.0% -4.43% -6.74%
Cost Of Revenue $2.785M $640.0K $3.129M
YoY Change -10.99% -28.89% 12.31%
Gross Profit $10.39M $2.810M $11.60M
YoY Change -10.47% 3.69% -1.46%
Gross Profit Margin 125.16% 81.45% 139.8%
Selling, General & Admin $6.444M $2.030M $6.935M
YoY Change -7.08% 47.1% 6.77%
% of Gross Profit 62.03% 72.24% 59.77%
Research & Development $3.336M $830.0K $2.836M
YoY Change 17.63% 20.29% -13.64%
% of Gross Profit 32.11% 29.54% 24.44%
Depreciation & Amortization $224.0K $200.0K $197.0K
YoY Change 13.71% 0.0% -19.26%
% of Gross Profit 2.16% 7.12% 1.7%
Operating Expenses $9.780M $2.860M $9.773M
YoY Change 0.07% 38.83% -1.51%
Operating Profit $608.0K -$50.00K $1.830M
YoY Change -66.78% -107.69% -1.19%
Interest Expense -$7.000K
YoY Change
% of Operating Profit -1.15%
Other Income/Expense, Net
YoY Change
Pretax Income $601.0K -$50.00K $1.830M
YoY Change -67.16% -109.8% -1.19%
Income Tax -$462.0K $40.00K -$5.165M
% Of Pretax Income -76.87% -282.24%
Net Earnings $1.063M -$90.00K $6.995M
YoY Change -84.8% -117.31% 275.67%
Net Earnings / Revenue 12.81% -2.61% 84.28%
Basic Earnings Per Share $0.20 $1.33
Diluted Earnings Per Share $0.20 -$0.02 $1.33
COMMON SHARES
Basic Shares Outstanding 5.296M shares 5.316M shares 5.244M shares
Diluted Shares Outstanding 5.316M shares 5.268M shares

Balance Sheet

Concept 2020 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.605M $5.120M $5.118M
YoY Change 68.13% 20.75% 20.82%
Cash & Equivalents $8.605M $5.118M $5.118M
Short-Term Investments
Other Short-Term Assets $480.0K $460.0K $463.0K
YoY Change 3.67% 12.2% 12.93%
Inventory $770.0K $781.0K $781.0K
Prepaid Expenses
Receivables $2.261M $3.126M $3.126M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.12M $9.488M $9.488M
YoY Change 27.7% -2.84% -2.84%
LONG-TERM ASSETS
Property, Plant & Equipment $439.0K $419.0K $600.0K
YoY Change -26.83% 21.1% 73.41%
Goodwill
YoY Change
Intangibles $3.875M
YoY Change 16.82%
Long-Term Investments
YoY Change
Other Assets $5.708M $5.220M $5.220M
YoY Change 9.35% 8600.0% 9221.43%
Total Long-Term Assets $9.308M $9.695M $9.695M
YoY Change -3.99% 160.69% 160.69%
TOTAL ASSETS
Total Short-Term Assets $12.12M $9.488M $9.488M
Total Long-Term Assets $9.308M $9.695M $9.695M
Total Assets $21.42M $19.18M $19.18M
YoY Change 11.68% 42.26% 42.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $547.0K $373.0K $373.0K
YoY Change 46.65% -57.52% -57.52%
Accrued Expenses $274.0K $270.0K $268.0K
YoY Change 2.24% 22.73% 19.64%
Deferred Revenue
YoY Change
Short-Term Debt $349.0K $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.472M $1.231M $1.231M
YoY Change 19.58% -56.76% -56.76%
LONG-TERM LIABILITIES
Long-Term Debt $574.0K $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.000K $20.00K $19.00K
YoY Change -57.89%
Total Long-Term Liabilities $582.0K $0.00 $19.00K
YoY Change 2963.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.472M $1.231M $1.231M
Total Long-Term Liabilities $582.0K $0.00 $19.00K
Total Liabilities $2.054M $1.250M $1.250M
YoY Change 64.32% -56.09% -56.09%
SHAREHOLDERS EQUITY
Retained Earnings -$6.565M
YoY Change -51.7%
Common Stock $53.00K
YoY Change 1.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.37M $17.93M $17.93M
YoY Change
Total Liabilities & Shareholders Equity $21.42M $19.18M $19.18M
YoY Change 11.68% 42.26% 42.26%

Cashflow Statement

Concept 2020 2019 Q4 2019
OPERATING ACTIVITIES
Net Income $1.063M -$90.00K $6.995M
YoY Change -84.8% -117.31% 275.67%
Depreciation, Depletion And Amortization $224.0K $200.0K $197.0K
YoY Change 13.71% 0.0% -19.26%
Cash From Operating Activities $2.560M $370.0K $2.250M
YoY Change 13.78% -62.24% 35.38%
INVESTING ACTIVITIES
Capital Expenditures $129.0K $130.0K $254.0K
YoY Change -49.21% -50.0% 30.93%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$151.0K -$130.0K -$1.410M
YoY Change -89.29% -50.0% 153.6%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $918.0K 0.000 -$17.00K
YoY Change -5500.0% 70.0%
NET CHANGE
Cash From Operating Activities $2.560M 370.0K $2.250M
Cash From Investing Activities -$151.0K -130.0K -$1.410M
Cash From Financing Activities $918.0K 0.000 -$17.00K
Net Change In Cash $3.327M 240.0K $823.0K
YoY Change 304.25% -66.67% -24.91%
FREE CASH FLOW
Cash From Operating Activities $2.560M $370.0K $2.250M
Capital Expenditures $129.0K $130.0K $254.0K
Free Cash Flow $2.431M $240.0K $1.996M
YoY Change 21.79% -66.67% 35.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 isns Operating Lease Extended Term
OperatingLeaseExtendedTerm
P1Y
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5118000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
6995000 USD
CY2018Q4 isns Operating Lease Obligation
OperatingLeaseObligation
431000 USD
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Registrant Name
EntityRegistrantName
IMAGE SENSING SYSTEMS INC
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0000943034
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Entity File Number
EntityFileNumber
0-26056
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1519168
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
400 Spruce Tree Centre,
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
1600 University Avenue West
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
St. Paul
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55104
CY2020 dei City Area Code
CityAreaCode
(651)
CY2020 dei Local Phone Number
LocalPhoneNumber
603-7700
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020Q2 dei Entity Public Float
EntityPublicFloat
13011983 USD
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5352626 shares
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8605000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5118000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
19000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2261000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3126000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
770000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
781000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
480000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
463000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
12116000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
9488000 USD
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
154000 USD
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
163000 USD
CY2020Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
6000 USD
CY2019Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
6000 USD
CY2020Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1215000 USD
CY2019Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1339000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1375000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1508000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1072000 USD
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5268000 shares
CY2020 us-gaap Net Income Loss
NetIncomeLoss
1063000 USD
CY2020Q4 us-gaap Assets
Assets
21424000 USD
CY2019Q4 us-gaap Assets
Assets
19183000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1089000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
303000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
419000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3161000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3875000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5708000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5220000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
136000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
181000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
313000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
547000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
373000 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
37000 USD
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
28000 USD
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
141000 USD
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
313000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
148000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
105000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
126000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
181000 USD
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
349000 USD
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
124000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
231000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1472000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1231000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
574000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2054000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1250000 USD
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5352626 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5352626 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5322849 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5322849 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
54000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
53000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24968000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24751000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-150000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-306000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5502000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6565000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
19370000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
17933000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21424000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19183000 USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13173000 USD
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14732000 USD
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
2785000 USD
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
3129000 USD
CY2020 us-gaap Gross Profit
GrossProfit
10388000 USD
CY2019 us-gaap Gross Profit
GrossProfit
11603000 USD
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2546000 USD
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2676000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3898000 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4259000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3336000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2836000 USD
CY2020 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2019 us-gaap Restructuring Charges
RestructuringCharges
2000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
9780000 USD
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5296000 shares
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2019 us-gaap Operating Expenses
OperatingExpenses
9773000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
608000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
1830000 USD
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
7000 USD
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
0 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
601000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1830000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-462000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5165000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
1063000 USD
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5244000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5316000 shares
CY2020 us-gaap Net Income Loss
NetIncomeLoss
1063000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
6995000 USD
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
156000 USD
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
66000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1219000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7061000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
1063000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
6995000 USD
CY2020 us-gaap Depreciation
Depreciation
224000 USD
CY2019 us-gaap Depreciation
Depreciation
197000 USD
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
736000 USD
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
598000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
224000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
219000 USD
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-489000 USD
CY2019 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-5162000 USD
CY2020 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-5000 USD
CY2019 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-865000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-704000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-508000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
53000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
187000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-514000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-249000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2560000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2250000 USD
CY2020 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
22000 USD
CY2019 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1156000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
129000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
254000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-151000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1410000 USD
CY2020 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
924000 USD
CY2019 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6000 USD
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
21000 USD
CY2020 us-gaap Gross Profit
GrossProfit
10388000 USD
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
918000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
160000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
59000 USD
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3487000 USD
CY2019 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
882000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5118000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4236000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8605000 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1000 USD
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
14000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
10637000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
219000 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000 USD
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
21000 USD
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
66000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
17933000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
224000 USD
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6000 USD
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
156000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
1063000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
19370000 USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13173000 USD
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14732000 USD
CY2020 isns Royalty Percentage Of Gross Profit On Licensed Products
RoyaltyPercentageOfGrossProfitOnLicensedProducts
0.50 pure
CY2020 isns Amortization Period For Expense Sales Commissions Incurred Maximum
AmortizationPeriodForExpenseSalesCommissionsIncurredMaximum
P1Y
CY2020 isns Period For Value Of Unsatisfied Performance Obligations Which Not Disclosed
PeriodForValueOfUnsatisfiedPerformanceObligationsWhichNotDisclosed
P1Y
CY2020Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
22000 USD
CY2019Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
1200000 USD
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0 USD
CY2020Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0 USD
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15320 shares
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9488 shares
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin: 0in 0in 11pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;">USE OF ESTIMATES</span></p> <p style="margin: 0in 0in 0pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;">The preparation of financial statements in accordance with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expense during the reporting period. Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. Ultimate results could differ from those estimates. Changes in these estimates will be reflected in the financial statements in future periods. Significant estimates include warranty reserves, allowance for doubtful accounts, inventory reserves, and the valuation of deferred tax assets. </span></p>
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
661000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
551000 USD
CY2020Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
109000 USD
CY2019Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
230000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
770000 USD
CY2018Q4 isns Operating Lease Asset
OperatingLeaseAsset
431000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
247000 USD
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
265000 USD
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
284000 USD
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
306000 USD
CY2020 us-gaap Lease Cost
LeaseCost
531000 USD
CY2019 us-gaap Lease Cost
LeaseCost
571000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
128000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
136000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
134000 USD
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0475 pure
CY2020 isns Payments For Operating Lease Liabilities
PaymentsForOperatingLeaseLiabilities
250000 USD
CY2019 isns Payments For Operating Lease Liabilities
PaymentsForOperatingLeaseLiabilities
264000 USD
CY2020Q2 isns Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
194000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5477000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2316000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3161000 USD
CY2020 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P7Y3M18D
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9355000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5480000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3875000 USD
CY2019 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P7Y1M6D
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
749000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
690000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
631000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
540000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
265000 USD
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
656000 USD
CY2020 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
35000 USD
CY2019 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
71000 USD
CY2020 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
63000 USD
CY2019 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
81000 USD
CY2020 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-144000 USD
CY2019 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-333000 USD
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
141000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
313000 USD
CY2020 isns Schedule Of Components Of Loss Before Income Taxes
ScheduleOfComponentsOfLossBeforeIncomeTaxes
<p style="margin: 0pt 0pt 8pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">The components of income before income taxes were as follows (in thousands):</span></p> <div style="border-right: none; border-left: none;"> <div style="border-left: none; border-right: none;"> <table cellpadding="0" style="height: 125px; border-collapse: collapse; width: 80%; margin-right: auto; font-family: 'times new roman'; font-size: 10pt; margin-left: auto;" width="80%"> <tbody> <tr style="height: 11.25pt;"> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 17px;"> <p style="line-height: 12pt; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td colspan="7" style="border-bottom: 1pt solid #000000; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 17px;"> <p style="line-height: 11.25pt; margin: 0pt; text-align: center;"><span style="font-family: 'times new roman', times; font-size: 8pt; font-weight: bold;"> Years ended December 31, </span></p> </td> </tr> <tr style="height: 11.25pt;"> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 18px;"> <p style="line-height: 12pt; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td colspan="3" style="border-bottom: 1pt solid #000000; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 18px;"> <p style="line-height: 11.25pt; margin: 0pt; text-align: center;"><span style="font-family: 'times new roman', times; font-size: 8pt; font-weight: bold;"> 2020 </span></p> </td> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 18px;"> <p style="line-height: 12pt; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 8pt;">   </span></p> </td> <td colspan="3" style="border-bottom: 1pt solid #000000; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 18px;"> <p style="line-height: 11.25pt; margin: 0pt; text-align: center;"><span style="font-family: 'times new roman', times; font-size: 8pt; font-weight: bold;"> 2019 </span></p> </td> </tr> <tr style="height: 5.25pt;"> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 17px;"> <p style="line-height: 12pt; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 17px;"> <p style="line-height: 12pt; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; height: 17px;"> <p style="line-height: 12pt; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; height: 17px;"> <p style="line-height: 12pt; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 17px;"> <p style="line-height: 12pt; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 17px;"> <p style="line-height: 12pt; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; height: 17px;"> <p style="line-height: 12pt; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; height: 17px;"> <p style="line-height: 12pt; margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> </tr> <tr style="background-color: #d6f3e8;"> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; background-color: #d6f3e8; height: 18px; width: 60%;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> Income from operations before income taxes  </span></p> </td> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; background-color: #d6f3e8; height: 18px; width: 4%;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; background-color: #d6f3e8; height: 18px; width: 13%;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; background-color: #d6f3e8; height: 18px; width: 1%;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; background-color: #d6f3e8; height: 18px; width: 4%;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; background-color: #d6f3e8; height: 18px; width: 4%;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; background-color: #d6f3e8; height: 18px; width: 13%;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; background-color: #d6f3e8; height: 18px; width: 1%;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> </tr> <tr style="height: 12.75pt;"> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 18px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> Domestic </span></p> </td> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 18px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> $ </span></p> </td> <td style="padding: 0px; vertical-align: bottom; text-align: right; height: 18px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">(490</span></p> </td> <td style="padding: 0px; vertical-align: bottom; text-align: right; height: 18px;"> <p style="margin: 0pt; text-align: left;"><span style="font-family: 'times new roman', times; font-size: 10pt;">)  </span></p> </td> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 18px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 18px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> $ </span></p> </td> <td style="padding: 0px; vertical-align: bottom; height: 18px;"> <p style="margin: 0pt; text-align: right;"><span style="font-family: 'times new roman', times; font-size: 10pt;">         2,081 </span></p> </td> <td style="padding: 0px; vertical-align: bottom; height: 18px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> </tr> <tr style="height: 12.75pt; background-color: #d6f3e8;"> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; background-color: #d6f3e8; height: 18px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> Foreign </span></p> </td> <td style="border-bottom: 1pt solid #000000; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; background-color: #d6f3e8; height: 18px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; text-align: right; background-color: #d6f3e8; height: 18px;"> <p style="margin: 0pt; text-align: right;"><span style="font-family: 'times new roman', times; font-size: 10pt;">28</span></p> </td> <td style="padding: 0px; vertical-align: bottom; background-color: #d6f3e8; height: 18px;"/> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; background-color: #d6f3e8; height: 18px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="border-bottom: 1pt solid #000000; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; background-color: #d6f3e8; height: 18px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="padding: 0px; vertical-align: bottom; background-color: #d6f3e8; height: 18px;"> <p style="margin: 0pt; text-align: right;"><span style="font-family: 'times new roman', times; font-size: 10pt;">           (251</span></p> </td> <td style="padding: 0px; vertical-align: bottom; background-color: #d6f3e8; height: 18px;"> <p style="margin: 0pt; text-align: left;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> ) </span></p> </td> </tr> <tr style="height: 13.5pt;"> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 19px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> Total </span></p> </td> <td style="border-bottom: 2.25pt double #000000; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 19px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> $ </span></p> </td> <td style="border-bottom: 2.25pt double #000000; border-top: 1pt solid #000000; padding: 0px; vertical-align: bottom; height: 19px;"> <p style="margin: 0pt; text-align: right;"><span style="font-family: 'times new roman', times; font-size: 10pt;">(462</span></p> </td> <td style="border-bottom: 2.25pt double #000000; border-top: 1pt solid #000000; padding: 0px; vertical-align: bottom; height: 19px;"> <p style="margin: 0pt; text-align: left;"><span style="font-family: 'times new roman', times; font-size: 10pt;">)  </span></p> </td> <td style="padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 19px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> <td style="border-bottom: 2.25pt double #000000; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom; height: 19px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> $ </span></p> </td> <td style="border-bottom: 2.25pt double #000000; border-top: 1pt solid #000000; padding: 0px; vertical-align: bottom; height: 19px;"> <p style="margin: 0pt; text-align: right;"><span style="font-family: 'times new roman', times; font-size: 10pt;">1,830 </span></p> </td> <td style="border-bottom: 2.25pt double #000000; border-top: 1pt solid #000000; padding: 0px; vertical-align: bottom; height: 19px;"> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 10pt;">   </span></p> </td> </tr> </tbody> </table> </div> </div> <p style="margin: 0pt;"><span style="font-family: 'times new roman', times; font-size: 7pt;"> </span></p>
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-490000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2081000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
28000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-251000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-462000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1830000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-9000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
22000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
3000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
26000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-6000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-461000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5195000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-33000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
6000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
36000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-488000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5159000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-462000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5165000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
143000 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
384000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-31000 USD
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-185000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
0 USD
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-5246000 USD
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
125000 USD
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
184000 USD
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
6000 USD
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
0 USD
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-137000 USD
CY2019 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
16000 USD
CY2020 isns Income Tax Reconciliation Deferred True Up
IncomeTaxReconciliationDeferredTrueUp
-226000 USD
CY2019 isns Income Tax Reconciliation Deferred True Up
IncomeTaxReconciliationDeferredTrueUp
0 USD
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-92000 USD
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
50000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-462000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5165000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
7000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
14000 USD
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
3000 USD
CY2019Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
9000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
0 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
1000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
52000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
52000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
15000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
62000 USD
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
-158000 USD
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
-43000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4756000 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4533000 USD
CY2020Q4 isns Deferred Tax Assets Property Plant And Equipment And Other
DeferredTaxAssetsPropertyPlantAndEquipmentAndOther
-10000 USD
CY2019Q4 isns Deferred Tax Assets Property Plant And Equipment And Other
DeferredTaxAssetsPropertyPlantAndEquipmentAndOther
-233000 USD
CY2020Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2890000 USD
CY2019Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2672000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7451000 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6963000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1743000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1743000 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
5708000 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
5220000 USD
CY2020 us-gaap Other Noncash Income Tax Expense
OtherNoncashIncomeTaxExpense
5200000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5300000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1700000 USD
CY2020 isns License Termination Description
LicenseTerminationDescription
The agreement’s term expires in 2031, unless terminated by either party upon three years’ notice.
CY2019 us-gaap Revenues
Revenues
8300000 USD
CY2020 us-gaap Revenues
Revenues
8300000 USD
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
94000 USD
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
106000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
224000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
219000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
149735 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.73
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y11M19D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3505000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2020 isns Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateIntrinsicValue
0 USD
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020 isns Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodTotalIntrinsicValue
0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1000 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.22
CY2020 isns Share Based Compensation Arrangement By Share Based Payment Award Options Forfeiture In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureInPeriodTotalIntrinsicValue
0 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.76
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y11M8D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2700000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
15000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.76
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y11M8D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2700000 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
39000 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.26
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y9M18D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4480000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2019 isns Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateIntrinsicValue
0 USD
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1000 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.22
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
950000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
18000 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.19
CY2019 isns Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodTotalIntrinsicValue
0 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.73
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y11M19D
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3505000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
The restricted stock awards granted to executive officers vest if the various performance or time-based metrics are met.
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.22
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.73
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y11M19D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3505000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
16000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
58961 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.32
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
58877 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.22
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
31455 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.97
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
59230 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.95
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
57086 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.01
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
47320 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.05
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
11826 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
3.04
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
33330 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.52
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
58961 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.32
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15320 shares
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9488 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5268000 shares
CY2019 us-gaap Net Income Loss
NetIncomeLoss
6995000 USD
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5244000 shares
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
20000 shares
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
24000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5316000 shares
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
CY2020 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0 USD
CY2019 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
2000 USD
CY2020Q4 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
69000 USD
CY2019Q4 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
6000 USD
CY2020 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13173000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3161000 USD
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14732000 USD
CY2019 us-gaap Gross Profit
GrossProfit
11603000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
598000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3875000 USD

Files In Submission

Name View Source Status
0000897101-21-000169-index-headers.html Edgar Link pending
0000897101-21-000169-index.html Edgar Link pending
0000897101-21-000169.txt Edgar Link pending
0000897101-21-000169-xbrl.zip Edgar Link pending
ex21_2.htm Edgar Link pending
ex231_3.htm Edgar Link pending
ex311_4.htm Edgar Link pending
ex312_5.htm Edgar Link pending
ex321_6.htm Edgar Link pending
ex322_7.htm Edgar Link pending
ex46_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
imgi4h3hdsb2y402292909.jpg Edgar Link pending
isns-20201231.htm Edgar Link pending
isns-20201231.xsd Edgar Link pending
isns-20201231_cal.xml Edgar Link unprocessable
isns-20201231_def.xml Edgar Link unprocessable
isns-20201231_htm.xml Edgar Link completed
isns-20201231_lab.xml Edgar Link unprocessable
isns-20201231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending